. Number of cases (and controls) required in a casecontrol study designed to detect the stated relative risks of factors occurring with the stated frequency in the control population. All sample sizes assume a test ofsignificance at the 5% level and a power of 90%
Cases
The next problem is to define and find the cases. This causes great controversy in some fields especially with chronic diseases that take years to develop. It has been a problem in cataract studies. Specialists have differing opinions about when the increasing opacity of the lens as aging occurs should be called a cataract. One golden rule for case-control studies is to keep the criteria simple: a good definition of a cataract patient for a study may be a patient who has had a cataract surgically removed. An alternative definition would be those on the waiting list for cataract surgery. These simple definitions ensure, at least in NHS hospitals, that the cataract is more than the mere haziness seen in most of the population over sixty.
Controls
Next comes the major potential pitfall-the choice of controls. They are supposed to be similar in every way to the cases except that they do not have the disease. In many studies they are taken from the same hospital; indeed some epidemiologists assert that they must be taken from the same hospital. This is not necessarily a good idea. A study of glaucoma where the controls were from the same Eye Hospital and of the same age range might identify diabetes as a negative risk factor, apparently a protective factor against glaucoma, simply because most of the elderly non-glaucoma patients in eye hospitals are cataract patients, and diabetes is strongly associated with an increased risk of cataract. Other hospital departments may be a better source of controls. A wide range of diagnoses helps to avoid this problem. In our own studies 2 Starting a case-control study A case-control study is the most efficient way to find risk factors for a disease.
A case-control study appears to be very simple: a number of people with a disease are compared with the same number, or perhaps rather more people, without the disease. Certain decisions have to be made early on and these are: How many cases?How many controls? (i.e. those without disease). How is the disease defined? Who are the cases? Where are suitable controls to be found? What features are to be compared? Once these decisions are made the design of the study is almost settled, but before getting down to the detailed design it is most important to know why the study is being done -what hypotheses are to be tested? A vague desire to carry out a case-control study of a favourite disease is not enough. The hypotheses must be precisely expressed and must be testable. The hypotheses must be worth testing in the light of all that is known about the disease. Even for a study where risk factors are being sought as well as tested -a 'fishing expedition'the questions to be addressed should be framed clearly. For example: 'Do any commonly-taken drugs consumed regularly for at least 4 months cause cataract?'
Numbers
Tables to help decide on the numbers of cases and controls are given in many epidemiological texts ( Table 1 ). Note that the numbers required depend strongly on the relative risk of the factor to be detected, and on the prevalence of that factor in the community. For example, if the factor of interest is thought to cause a 5-fold increase in risk and occurs in 5% of the normal population then at least 92 cases and 92 controls will be required. Ifthe factor increased the risk by only 20% then thousands of cases and of controls would be needed. Myopia in early life has been reported by about 7% of a control population aged 50-79 years 2 • Therefore a case-control study to test whether myopia when young is associated with cataracts in later life would require close to a thousand subjects divided between the case and control groups. The study that demonstrated this risk factor was approximately that size 2 • Many studies aim to identify only risk factors that are relatively common in the general population and which approximately double the risk of the disease. Even then hundreds of cases and hundreds of controls will be required.
The number of controls is often equal to that ofcases but can be greater; especially useful if there is to be more than one source of controls because data from these different sources can be compared before comparing pooled controls with cases. included many terminally-ill patients taking a wide variety of unusual drugs, and were quite unlike the cataract and ENT patients. An alternative is to go into the wider community for controls. There are dangers here too. Volunteers who have to make positive efforts are always suspect. We recruited some controls via the age-sex register of local general practitioners''. Three groups were used to give a good geographical and socioeconomic spread.
These are some of the major points to be decided before starting the interview or examinations. A recent paper lists the information considered essential for the interpretation of case-control studies''. The list covers many of the points already discussed, and several additional ones notably the non-response rate. If only a minority of those asked to participate in a study accept the invitation then the study may not be valid. Even an 80% response rate leaves some doubts, because the 20% who do not respond may differ in many ways from those who do respond. In particular they may take less care of their health. The initial approach to subjects is of major importance in maintaining a high response rate. It is also important to inconvenience the subjects as little as possible.
Oxford case-control study In our case-control study in Oxford the main impetus was to test the diarrhoeal hypothesis, which proposed that severe diarrhoea was a major cause of cataract in some countrles", We planned the study before the results of the case-control study on diarrhoea and cataract in Raipur, India, were published". It was far less likely that diarrhoea would be a major risk factor in the Oxford population but we thought it worth investigating. We looked at occupation and place of work as possible risk factors, thinking, for example, that working at Harwell (Atomic Energy Research Establishment) could be hazardous. We also wanted to look again at drugs, alcohol and cigarettes as risk factors following the findings of the Edinburgh study", The drug question was very general. The study was based entirely on a questionnaire. Ruth van Heyningen interviewed 300 cataract patients on the ward and 609 controls all between the ages of 50 and 79 years. We ensured that the age-sex distribution was similar not only for cases and controls but for each of the 4 groups of controls'. Odds ratios calculated from contingency tables were taken as valid estimates of the relative risks. Thus we identified a number of risk factors that were already well-known including diabetes, glaucoma and consumption of steroids 3 ,4,9. Glaucoma Glaucoma is a powerful risk factor (relative risk 6.0 with 95% confidence limits 2.6 and 13.5;see ref4) with little difference in risk between the sexes (males 5.4, females 6.7). Stratifying by age, the relatively small number of glaucoma patients aged less than 70 years could be eliminated, leaving a somewhat higher risk in septuagenarians (relative risk 8.6 with 95% confidence limits 2.8 to 26.3).
After identification of glaucoma as a risk factor the patients' hospital notes (cases and controls) were examined for further clues. First the notes confirmed that all those reporting glaucoma had glaucoma (two borderline). They also demonstrated an almost equal representation of open and closed angle glaucoma. More than half the cases with glaucoma had had operations (trabeculectomy or iridectomy) but none of the controls had been operated on for glaucoma. This indicates that the trauma associated with glaucoma surgery might cause cataract.
Severe diarrhoea
Severe diarrhoea appeared as a risk factor even in the Oxford population". More than two-thirds ofthe male cataract patients reporting severe diarrhoea were reporting episodes dating from military service mostly in the Far East and North Africa, and mostly during the 1939-1945 war. This adds further support to the view that there can be an interval of many years between an insult to the lens and the resulting cataract.
Myopia
Myopia in early life appeared as a risk factor in our population", This relationship had been proposed by Weale-? but is not easily investigated because there is a myopic shift during the formation of cataract!'. To avoid this problem the subjects (300 cases and 609 controls) were asked if they were short-sighted when young. If they were unsure, they were asked if they wore spectacles when young and if so whether they were for reading or for distant vision. The percentage reporting myopia was greater for cataract patients (13.7%) than for controls ('1.2%) and thus myopia when young appeared as a significant risk factor: relative risk 2.0, p=0.002. The study by Brown and Hill also addressed this problem but it was based on orily 110 cataract patients and 110 controls, insufficient to test the question (Table I) .
Causal relationships?
A surprise result from our study was that paracetamol, aspirin, ibuprofen and similar drugs were associated with a decreased risk of cataract 3 ,9. The relative risk was less than unity indicating a protective effect.
The final task in a case-control study is to consider whether or not the associations which have been identified are causal associations. Does diabetes itself cause cataract or is it associated with another factor that causes cataract? In this instance there is evidence from earlier epidemiological studies, from animal studies and from in vitro studies to support the view that diabetes can cause cataract.
The same approach must be adopted for a protective effect such as that associated with consumption of aspirin-like analgesics. There is some corroboration from small studies on aspirin users 12 and from laboratory experiments'". However, a protective effect of a drug must ultimately be tested by intervention in a clinical trial attempting to slow the progress of early cataract using one or more of the aspirin-like analgesics. 
